Thrombosis and Haemostasis

Article	Citations
COVID-19 Patients Putting on the Brakes with PAR1 Autoantibodies	104
	94
	81
Venous Thrombosis Associated with Different Types of SARS-CoV-2 Vaccines in the Netherlands—Results of the TERA Case-Control Study	74
Heparin and Direct Oral Anticoagulants have Different Effects on the Phases of Activation and Spatial Spread of Blood Coagulation	70
Commentary: “No Genetic Causality between Tobacco Smoking and Venous Thromboembolism: A Two-Sample Mendelian Randomization Study”	55
Platelet P2Y12 Inhibitor Monotherapy after Percutaneous Coronary Intervention: An Emerging Option for Antiplatelet Therapy De-escalation	48
High anti-ADAMTS13 IgG Levels after Plasma Exchange Predict Delayed ADAMTS13 Normalization in Immune-mediated Thrombotic Thrombocytopenic Purpura	48
Association between Clot Waveform Analysis Parameters and the Severity of Liver Cirrhosis	46
Heterogeneity in American and European Peripheral Artery Disease Guidelines on Non-statin Lipid-Lowering Therapy and Rivaroxaban	40
	40
Predictors, Incidence, and Proximal Extension Rate of Distal Deep Vein Thrombosis in Internal Medicine Wards: Insights from the AURELIO Study	40
Atherosclerotic Autoantigen ALDH4A1 as a Novel Immunological Indicator for Plaque Erosion in Patients with ST Segment Elevated Myocardial Infarction	39
Assessing Clinically Meaningful Hypercoagulability after COVID-19 Vaccination: A Longitudinal Study	34
Clinical and Genetic Characterization of 51 Patients with Congenital Fibrinogen Disorders from China	33
Machine Learning-Based Predictive Models for Patients with Venous Thromboembolism: A Systematic Review	32
	29
	28
A Rollercoaster Plunge into 2022	27
The Effect of Increasing Factor X Levels on Emicizumab-Driven Coagulation Potential	26
Methoxyflurane Instead of Morphine in Acute Coronary Syndrome Patients: Results of the Randomized Controlled METHANE-SIRIO 4 Study	24
Statin Treatment and the Alterations in the Platelet Lipidome: What Is the Impact of Lipid Profile on Thrombosis?	24
Strategies for Tailored Antiplatelet Therapy after Percutaneous Coronary Intervention: Unraveling Complexities, Embracing Nuances	23
Reflections on World Thrombosis Day 2024	23
Survival Implications of Thrombus Recurrence or Bleeding in Cancer Patients Receiving Anticoagulation for Venous Thromboembolism Treatment	22

3-Factor versus 4-Factor Prothrombin Complex Concentrates for the Reversal of Vitamin K Antagonist-Associated Coagulopathy: A Systematic Review and Meta-analysis	22
Risk of Bleeding in Liver Cirrhosis Receiving Direct Oral Anticoagulants: A Systematic Review and Meta-analysis	21
The Story of the Fibrin(ogen) αC-Domains: Evolution of Our View on Their Structure and Interactions	21
Carotid Stenosis and Stroke: Medicines, Stents, Surgery—“Wait-and-See” or Protect?	21
Cardiac Repair after Myocardial Infarction is Controlled by a Complement C5a Receptor 1-Driven Signaling Cascade	21
Circulating Levels of Low-Density Granulocytes and Cell-Free DNA as Predictors of Cardiovascular Disease and Bone Deterioration in SLE Patients	21
Obesity and Pulmonary Embolism: Can We Dismantle the “Obesity Paradox”	20
Gaining Insights into Inherited Bleeding Disorders of Complex Etiology in Pediatric Patients: Whole-Exome Sequencing as First-Line Investigation Tool	20
Volume Regulation and Nonosmotic Volume of Individual Human Platelets Quantified by High-Speed Scanning Ion Conductance Microscopy	20
The Impact of Polypharmacy on the Effectiveness and Safety of Non-vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation	20
Open Issues in the Choice and Management of Direct Oral Anticoagulants in Patients with Cancer-Related Venous Thromboembolism	19
Are More Patients with Thromboembolic Disease Dying Now Than Before?	19
Von Willebrand Factor as a Therapeutic Target in Thrombotic Disorders	18
Longitudinal In Vivo Monitoring of Atheroprogression in Hypercholesterolemic Mice Using Photoacoustic Imaging	18
Warfarin—Is Self-Care the Best Care?	18
Performance and Head-to-Head Comparison of Three Clinical Models to Predict Occurrence of Postthrombotic Syndrome: A Validation Study	18
Dose-Related Effectiveness of Andexanet Alfa for Reversal of Apixaban Anticoagulation in a Porcine Polytrauma Model	18
Do Patients with a Family or Personal History of Venous Thromboembolism have an Increased Risk of Recurrence?	18
Risk of Incident Atrial Fibrillation and Subsequent Use of Oral Anticoagulants in Patients with Dementia	17
Characterization and Usefulness of Clot-Fibrinolysis Waveform Analysis in Critical Care Patients with Enhanced or Suppressed Fibrinolysis	17
Enhancing Pulmonary Embolism Risk Stratification: The National Early Warning Score and Its Integration into the European Society of Cardiology Classification	17
Clopidogrel Monotherapy versus Aspirin Monotherapy in Patients with Established Cardiovascular Disease: Systematic Review and Meta-Analysis	16
Antithrombotic Prophylaxis with Rivaroxaban in Patients with Prehospital COVID-19: A Meta-analysis of Two Placebo-Controlled Trials	16
Dual Antiplatelet Therapy or Dual Pathway Inhibition	16
Effectiveness and Safety of Oral Anticoagulants in the Treatment of Acute Venous Thromboembolism: A Nationwide Comparative Cohort Study in France	16
Emerging Thrombotic Disorders Associated with Virus-Based Innovative Therapies: From VITT to AAV Gene Therapy–Related Thrombotic Microangiopathy	15
Disseminated Intravascular Coagulation Score Predicts Mortality in Patients with Liver Disease and Low Fibrinogen Level	15
Clinical Delphi on aPL Negativization: Report from the APS Study Group of the Italian Society for Rheumatology (SIR-APS)	15
Sensitivity to Aortic Rupture in Hereditary Aortic Diseases	15
Transfer RNAs are Linked to Ischemic Stroke and Major Bleeding in Patients with End-Stage Kidney Disease	15
Anti-thrombotic Effects Mediated by a Novel Dual-Target Peptide Inhibiting Both Platelet Aggregation and Thrombin Activity without Causing Bleeding	15
Pulmonary Thromboembolism after Catheter Ablation of Cardiac Arrhythmias	14
The Prognostic Value of the Age–D-Dimer–Albumin Score in Patients with Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention	14
Dual-Specificity Tyrosine Phosphorylation-Regulated Kinase 1B Inhibition Promotes Megakaryocyte Polyploidization and Platelet Production	14
Growth Differentiation Factor-15: A Novel Biomarker for Predicting Risk of Venous Thromboembolism and Bleeding in Patients with Cancer	13
CLEC-2 Supports Platelet Aggregation in Mouse but not Human Blood at Arterial Shear	13
Additional Factor X Enhances Emicizumab-Driven Coagulation Function in Patients with Hemophilia A and Hemophilia A Mice	13
Pathophysiological Aspects of COVID-19-Associated Vasculopathic Diseases	13
Novel Immunochromatographic Test for Anti-factor XIII B Subunit Autoantibodies to Diagnose Autoimmune Acquired Factor XIII Deficiency	13
Pregnancy after Combined Oral Contraceptive-Associated Venous Thromboembolism: An International Retrospective Study of Outcomes	13
N-Glycosylation Deficiency Reduces the Activation of Protein C and Disrupts Endothelial Barrier Integrity	13
Hyperresponsive Platelets and a Reduced Platelet Granule Release Capacity Are Associated with Severity and Mortality in COVID-19 Patients	13
Risk Factors for Venous Thromboembolism in Women of Childbearing Age	12
Cryofibrinogen—Characteristics and Association with Cryoglobulin: A Retrospective Study Out of a Series of 1,712 Samples over 7 Years	12
Continuous Improvement of Antiplatelet Therapy in Cardiovascular Disease	12
	12
Inhibition of Hypoxia-Inducible Factor Prolyl-Hydroxylase Modulates Platelet Function	12
Usual On-therapy Ranges of Drug Concentrations in Patients with Atrial Fibrillation Treated with Direct Oral Anticoagulants: A Systematic Review and Meta-analysis	12
Thrombosis and Haemostasis 2022 Editors' Choice Papers	12
Gene Abnormalities in Transplant Associated-Thrombotic Microangiopathy: Comparison between Recipient and Donor's DNA	12

	12
Association of Combined Lifestyle and Polygenetic Risk with Incidence of Venous Thromboembolism: A Large Population-Based Cohort Study	12
Early Time Courses of Recurrent Venous Thromboembolism and Bleeding during Apixaban or Dalteparin Therapy for Patients with Cancer	12
Hypercoagulability State in Predicting Severe Functional Outcome in Patients with Acute Ischemic Stroke: Cause, Consequence, or Both?	12
Kidney Disease and Cancer Risk in Patients with Venous Thromboembolism: What Does It Mean for Clinical Practice?	11
Diabetic Microvascular Disease and Risk of Peripheral Artery Disease, Foot Ulcer, Leg Infection, and Amputation	11
	11
Pharmacokinetics of Edoxaban 15 mg in Very Elderly Patients with Nonvalvular Atrial Fibrillation: A Subanalysis of the ELDERCARE-AF Study	11
Human Platelets Internalize Pregnancy-Specific Glycoprotein-1 (PSG1)	11
Brisk Walking Pace Offsets Venous Thromboembolism Risk Equivalent to Established Monogenic Mutations	11
Lymphoblasts Express Hemostatic Factors: A Mechanism for Hypercoagulability in Pediatric Acute Lymphoblastic Leukemia	11
Current View on the Molecular Mechanisms Underlying Fibrin(ogen)-Dependent Inflammation	11
Extravascular Binding of Coagulation Factor IX Gives Hemostasis a Boost	11
SARS-CoV-2 Vaccination: Long-Term Follow-Up of Pre-existing and De Novo Immune Thrombocytopenia	11
Activation of the Acute-Phase Response in Hemophilia	11
Inflammatory and Bleeding Risks on Clinical Outcomes in Acute Coronary Syndrome Patients Undergoing Percutaneous Coronary Intervention	11
Anticoagulation in Patients with Isolated Distal Deep Vein Thrombosis: Bringing the Puzzle Together	11
Landscape and Spectrum of VWF Variants in Type 2 Von Willebrand Disease: Insights from a German Patient Cohort	11
Expression of microRNA Predicts Cardiovascular Events in Patients with Stable Coronary Artery Disease	11
	11
Physical and Mechanobiological Basis of Biological Functions of Platelets	11
Functional Consequences of Antibodies against Noncatalytic B Subunit of Factor XIII	11
Pneumococcal Neuraminidases Increase Platelet Killing by Pneumolysin	11
Personalized Medicine, Public Health and Patient-Centred Aspects in the Prevention of Stroke in Intracerebral Haemorrhage Survivors with Atrial Fibrillation (PRESTIGE-AF) Project	11
Vaccine-Induced Immune Thrombotic Thrombocytopenia Two Years Later: Should It Still Be on the Scientific Agenda?	10
Psychometric Validation of the Hemophilia Functional Ability Scoring Tool (Hemo-FAST)	10
Factor XI Inhibitors or Direct Oral Anticoagulants in Atrial Fibrillation: A Focused Meta-analysis	10
External Validation of the Patient-Reported Villalta Scale for the Diagnosis of Postthrombotic Syndrome	10
Bacterial-Type Long-Chain Polyphosphates Bind Human Proteins in the Phosphatidylinositol Signaling Pathway	10
Blood Loss in Women of Childbearing Potential Taking Oral Anticoagulants for Venous Thromboembolism (The BLEED Study)	10
Growth Differentiation Factor-15, High-Sensitivity Cardiac Troponin T, and N-Terminal pro-B-type Natriuretic Peptide for Predicting Risk of Venous Thromboembolism in Ambulatory Cancer Patients Receivi	10
Impairment of Collagen-Induced Thrombus Formation in Microfluidic Assay Correlates with Bleeding Complications Better Than Cytofluorometric Parameters	10
Antithrombin Deficiency Is Associated with Prothrombotic Plasma Fibrin Clot Phenotype	10
Cost-Effectiveness of Performing Reference Ultrasonography in Patients with Deep Vein Thrombosis	9
Predicting Bleeding in Cancer-Associated Venous Thromboembolism: Another Milestone Achieved	9
Not Just CTEPH: A Narrative Review on the Spectrum Approach to Postpulmonary Embolism Conditions	9
Continuous Infusion of Factor VIII and von Willebrand Factor in Surgery: Trials with pdFVIII LFB or pdVWF LFB in Patients with Bleeding Disorders	9
Compromised PAR1 Activation—A Cause for Bleeding in XMEN?	9
Effectiveness and Safety of Apixaban versus Rivaroxaban in Patients with Atrial Fibrillation and Type 2 Diabetes Mellitus	9
Blood Coagulation and Beyond: Position Paper from the Fourth Maastricht Consensus Conference on Thrombosis	9
Prevention of Stroke in Intracerebral Haemorrhage Survivors with Atrial Fibrillation: Rationale and Design for PRESTIGE-AF Trial	9
Risk Factors for Postdischarge Major Thromboembolism and Mortality in Hospitalized Patients with COVID-19 with Cardiovascular Comorbidities: Insights from the CORE-19 Registry	9
	9
	9
High-Resolution Spatial Profiling Unveils Cellular Heterogeneity in Murine Atherosclerosis	8
Relationship Between Screening-Detected Atrial Fibrillation and Blood Pressure Levels in Elderly Hypertensive Patients: The OMRON Heart Study	8
	8
Reticulated Platelets: A Promising Prognosis Marker in Cardiovascular Diseases	8
Resting Heart Rate and Risk of Incident Venous Thromboembolism: The Tromsø Study	8
COVID-19 and Long-COVID Thrombosis: From Clinical and Basic Science to Therapeutics	8
Utility of Sepsis-induced Coagulopathy Among Disseminated Intravascular Coagulation Diagnostic Criteria: A Multicenter Retrospective Validation Study	8
Potential of Sulodexide in the Treatment of Diabetic Retinopathy and Retinal Vein Occlusion	8
The Role of Clot Waveform Analysis and Related Parameters in the Diagnosis and Treatment of Hemophilia A	8
Exploring Causal Relationships between Circulating Inflammatory Proteins and Thromboangiitis Obliterans: A Mendelian Randomization Study	8
The Association between Obstructive Sleep Apnea and Venous Thromboembolism: A Bidirectional Two-Sample Mendelian Randomization Study	8
	8
Patterns and Persistence of Anticoagulant Use in the Treatment of Venous Thromboembolism: Insights from South Korea	8
Ethnic Differences in Thrombotic Profiles of Acute Coronary Syndrome Patients and Relationship to Cardiovascular Outcomes: A Comparison of East Asian and White subjects	8
The Role of Oxidative Stress and MicroRNAs in Platelet Activation and the Efficacy of Antiplatelet Therapy in Acute Myocardial Infarction	8
	7
Addendum: Sex as a Risk Factor for Atrial Fibrillation-Related Stroke	7
Racial Differences in Bleeding Risks among Patients with Atrial Fibrillation: An Ecological Epidemiological Study Comparing Korea and UK Population	7
Blood Levels and Composition of Leukocyte-Platelet Aggregates in Inflammatory Diseases of Various Etiologies	7
Hyperfibrinolysis is Associated with Complement Activation Following Trauma	7
Novel Insights into the Aortic Mechanical Properties of Mice Modeling Hereditary Aortic Diseases	7
Lack of Formyl-peptide Receptor 1 Mitigates Atherosclerosis in Hyperlipidemic Mice	7
Usefulness and Limits of DOAC Removal Agents Based on Activated Charcoal in Thrombophilia Testing: Literature Review and Expert Proposals	7
Educational Attainment, Obesity, and Venous Thromboembolism. Is Only Matter of Weight?	7
Pharmacological Inhibition of Glycoprotein VI- and Integrin α2β1-Induced Thrombus Formation Modulated by the Collagen Type	7
The Effect of Protease-Activated Receptor-1 (PAR-1) Inhibition on Endothelial-Related Biomarkers in Patients with Coronary Artery Disease	7
	7
Navigating Anticoagulation in Ischemic Left Ventricular Aneurysms: Lessons from Cardiac Magnetic Resonance Imaging	7
Final Analysis Results from the AGEHA Study: Emicizumab Prophylaxis for Acquired Hemophilia A with or without Immunosuppressive Therapy	7
Risk Factors of Cardiovascular Death after Venous Thromboembolism: Results from a Prospective Cohort Study	7
Trypsin Activates Human Platelets via Proteolytic Cleavage of Protease-activated Receptor 4 (PAR4)	7
Elevated Thrombin Generation and Venous Thromboembolism Incidence in Patients Undergoing Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy Compared with Minimally Invasive Rectal Su	7
CXCL2 Mediates Lactate Secretion and Promotes Aortic Dissection Formation through the p38/JNK/C-myc Pathways	6
Concomitant Use of Selective Serotonin Reuptake Inhibitors and Oral Anticoagulants and Risk of Major Bleeding: A Systematic Review and Meta-analysis	6
An International Consensus Practical Guide on Left Atrial Appendage Closure for the Non-implanting Physician: Executive Summary	6
	6

Platelet Aggregation Is Not Altered in Men with Aortic Aneurysms	6
	6
	6
Ser252Asn Mutation Introduces a New N-Linked Glycosylation Site and Causes Type IIb Protein C Deficiency	6
De-escalation of DAPT—A Potential Strategy for Treating Ticagrelor-Related Dyspnea?	6
Association of Specific Antiphospholipid Antibodies to Platelet Count and Thrombocytopenia	6
Factor XIII-A Transglutaminase Contributes to Neutrophil Extracellular Trap (NET)-mediated Fibrin(ogen) Network Formation and Crosslinking	6
	6
Derivation and Validation of a COPD-specific Pulmonary Embolism Diagnostic Strategy	6
CM-352 Efficacy in a Mouse Model of Anticoagulant-Associated Intracranial Hemorrhage	6
	6
Exploring Pleiotropic Effects of Lipid Modifiers and Targets on Measures of the Coagulation System with Genetics	6
	6
Antiplatelet Therapy in Percutaneous Coronary Intervention Patients with Concurrent High Ischemic and Bleeding Risk	6
Unravelling the Causal Relationship between Endometriosis and the Risk for Developing Venous Thromboembolism: A Pooled Analysis	6
Performance of Bleeding Risk Scores for Major Bleeding in Anticoagulated Patients with Pulmonary Embolism: Insights from the CURES Registry-2	6
Effect of Alirocumab Added to High-Intensity Statin on Platelet Reactivity and Noncoding RNAs in Patients with AMI: A Substudy of the PACMAN-AMI Trial	6
A Happy New Year 2024 from Thrombosis and Haemostasis!	6
State-of-the-Art Mini Review: Dual-Pathway Inhibition to Reduce Arterial and Venous Thromboembolism	6
Neutrophil Extracellular Traps in the Infarct-Related Coronary Artery—A Marker or Mediator of Adverse Outcome?	6
The Risk of Incident Venous Thromboembolism Attributed to Overweight and Obesity: The Tromsø Study	6
One Year Prevalence of Venous Thromboembolism in Hospitalized COVID-19 Patients in France: Patients' Characteristics, Time Trends, and Outcomes	6
Association of Fibrinogen Variants with Severity of Obesity and Metabolic Liver Disease: 2-Year Follow-up after Bariatric Surgery	6